Literature DB >> 33135911

COVID-19 infection and the kidney.

Lucas Alvarez-Belon1, Alexander Sarnowski2, Lui G Forni3.   

Abstract

Despite initial reports, renal involvement, including acute kidney injury, has emerged as a serious complication of COVID-19 disease, particularly in critically ill patients. The reported prevalence varies considerably, which may reflect reporting practices, although differences in pre-existing comorbidities and socioeconomic factors, and differences between ethnic groups, almost certainly contribute. Renal involvement may present as an active urinary sediment or as changes in serum creatinine levels and urine output leading to acute kidney injury. In common with acute kidney injury complicating critical illness, the cause is often multifactorial and often presents as part of a multiorgan dysfunction syndrome. Treatment is, in the main, supportive, with kidney replacement therapy required in nearly 25% of reported cases. Few data currently exist as to the long-term burden of COVID-19-associated acute kidney injury but evidence suggests that only approximately one-third of patients are discharged with recovered renal function.

Entities:  

Keywords:  Acute kidney injury; COVID-19; Critical illness; Kidney replacement therapy

Mesh:

Year:  2020        PMID: 33135911     DOI: 10.12968/hmed.2020.0574

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN: 1750-8460            Impact factor:   0.825


  3 in total

Review 1.  COVID-19 and Acute Kidney Injury.

Authors:  James Hilton; Naomi Boyer; Mitra K Nadim; Lui G Forni; John A Kellum
Journal:  Crit Care Clin       Date:  2022-01-10       Impact factor: 3.879

2.  Incidence and risk factors of acute kidney injury in COVID-19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID-19: a systematic review and Meta-Analysis.

Authors:  Faraj K Alenezi; Mohammed A Almeshari; Rahul Mahida; Mansoor N Bangash; David R Thickett; Jaimin M Patel
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.

Authors:  Rusan Ali Catar; Maria Bartosova; Edyta Kawka; Lei Chen; Iva Marinovic; Conghui Zhang; Hongfan Zhao; Dashan Wu; Daniel Zickler; Honorata Stadnik; Marek Karczewski; Julian Kamhieh-Milz; Achim Jörres; Guido Moll; Claus Peter Schmitt; Janusz Witowski
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.